中文 Chinese
英文 English
Site Map
About Us
Company
Board
Management
Partnerships
Activities
Pipeline
Ibalizumab (TMB-355) Intravenous Infusion
Ibalizumab (TMB-355) Intravenous Push
Ibalizumab (TMB-355) Intramuscular Injection
TMB-365
TMB-370 (bispecific)
TMB-380 (VRC07-523LS)
News
Recent News
Announcement
Events
Biotech Column
Investor Relations
Company
Company Profile
Company Presentation
Corporate Governance
Organization
Board
Committee
Internal Audit
Major Internal Policies
Financials
Monthly Revenue
Financial Reports
Shareholders' Services
Major Shareholders
Dividend Information
Investor and Stock Information
Shareholder's Meeting
Contact Us
中文 Chinese
英文 English
Site Map
Latest News
2021-03-05
2020 Annual CEO Report
